Back

Targeting Macrophage Folate Receptor-β for Diagnosis and Treatment of Autoimmune Myocarditis

Jahandideh, A.; Atencio Herre, E.; Nammas, W.; Virta, J.; Liljenback, H.; Ponkamo, J.; Putri, A.; Zhuang, X.; Rajander, J.; Srinivasarao, M.; Low, P. S.; Lu, Y.; Li, X.-G.; Knuuti, J.; Roivainen, A.; Saraste, A.

2025-11-03 immunology
10.1101/2025.11.02.686077 bioRxiv
Show abstract

We investigated folate receptor-{beta} (FR-{beta}) expressed on activated macrophages as a therapeutic and imaging target in autoimmune myocarditis (AIM). Treatment with a folate-aminopterin conjugate (EC2319) targeting FR-{beta}-positive macrophages significantly reduced macrophage infiltration compared to saline (5.23 {+/-} 2.84% vs. 1.24 {+/-} 0.66%, P < 0.001) in rat experimental AIM. After immunization, FR-{beta} targeting positron emission tomography (PET) tracer [18F]FOL detected myocardial inflammatory lesions and revealed reduction in inflammation following EC2319 treatment relative to saline or tumor necrosis factor-alpha inhibitor Etanercept [standardized uptake value (SUV) 1.07 {+/-} 0.22 vs. 2.38 {+/-} 0.90 vs. 2.59 {+/-} 0.56, P < 0.001]. [18F]FOL PET signal correlated with myocardial CD68-positive macrophage content (r = 0.720, P < 0.001). These findings demonstrate that EC2319 attenuates myocardial inflammation in AIM and underscore the pathogenic role of FR-{beta}-positive macrophages. [18F]FOL PET provides a noninvasive means of detecting myocardial inflammatory activity and therapeutic response. Graphical abstract O_FIG O_LINKSMALLFIG WIDTH=200 HEIGHT=100 SRC="FIGDIR/small/686077v1_ufig1.gif" ALT="Figure 1"> View larger version (36K): org.highwire.dtl.DTLVardef@18e9296org.highwire.dtl.DTLVardef@139b8b3org.highwire.dtl.DTLVardef@8d1a74org.highwire.dtl.DTLVardef@1c3f06d_HPS_FORMAT_FIGEXP M_FIG C_FIG

Matching journals

The top 8 journals account for 50% of the predicted probability mass.

50% of probability mass above

"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.